Sweden · Who invested in IRLAB Therapeutics?
IRLAB Therapeutics's investors include EISMEA.
Sweden · Funded startup
Who invested in IRLAB Therapeutics
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2026, from 1 source
- Latest round
- Round, $11MMay 2026
- Investors
- 1
The rounds
- May 2026
Founders and team
From IRLAB Therapeutics's own website: 5 on the team.
- Nicholas WatersExecutive Vice President and Head of R&D
- Kristina TorfgårdCEO
- Gustaf AlbèrtChief Financial Officer (CFO)
- Joakim TedroffChief Medical Officer (CMO)
- Susanna Holm WatersDirector of Systems Pharmacology
Quick answers about IRLAB Therapeutics
How much has IRLAB Therapeutics raised?
IRLAB Therapeutics has raised $11M across 1 round since 2026.
When did IRLAB Therapeutics last raise?
IRLAB Therapeutics's most recent round was an Undisclosed round of $11M in May 2026.
What was IRLAB Therapeutics's biggest round?
Its most recent round, $11M in May 2026, is also its largest on record.
Who backed IRLAB Therapeutics first?
IRLAB Therapeutics's first round on record, in May 2026, was backed by EISMEA.
What stage is IRLAB Therapeutics at?
IRLAB Therapeutics's latest named round is an Undisclosed round, in May 2026.
Where is IRLAB Therapeutics based?
IRLAB Therapeutics is based in Sweden.
Companies like IRLAB Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.